Expert Review of Anticancer Therapy

译名:抗癌治疗专家综述

SCIEJCR Q3中科院4区

3-5

2026

影响因子区间

平台估算

投稿周期

19%

2025

中国作者发文占比

2650 USD

费用说明

收费

期刊简介:Expert Review of Anticancer Therapy (ISSN 1473-7140) provides expert appraisal and commentary on the major trends in cancer care and highlights the performance of new therapeutic and diagnostic approaches. Coverage includes tumor management, novel medicines, anticancer agents and chemotherapy, biological therapy, cancer vaccines, therapeutic indications, biomarkers and diagnostics, and treatment guidelines. All articles are subject to rigorous peer-review, and the journal makes an essential contribution to decision-making in cancer care. Comprehensive coverage in each review is complemented by the unique Expert Review format and includes the following sections: Expert Opinion - a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed resultsArticle Highlights – an executive summary of the author’s most critical points.

【译文】《抗癌治疗专家评论》(ISSN 1473-7140)提供了对癌症护理主要趋势的专家评估和评论,并突出了新的治疗和诊断方法的表现。涵盖内容包括肿瘤管理、新型药物、抗癌药物和化疗、生物治疗、癌症疫苗、治疗适应症、生物标志物和诊断以及治疗指南。所有文章都经过严格的同行评审,该期刊对癌症护理的决策做出了重要贡献。每个评论的全面覆盖都辅以独特的专家评论格式,包括以下部分:专家观点 - 对文章中呈现的数据的个人观点,对未来可能重要的进展的讨论,以及随着进一步研究产生更详细的结果可能变得令人兴奋的研究途径;文章亮点 - 作者最关键点的执行摘要。

出版社
Taylor & Francis
语言
English
学科
医学
ISSN
1473-7140
eISSN
1744-8328
出版频率
双月刊
创刊年份
2001
投稿网址
https://mc.manuscriptcentral.com/ert
最近更新
2026-04-02 18:16:40
Expert Review of Anticancer Therapy

指标当前值近三年趋势
JCR分区Q3
暂无
中科院分区4区
暂无
影响因子区间3-5
暂无